Last reviewed · How we verify
Microsatellite instability-high colorectal cancer
Approved treatments
- Yervoy · Bristol-Myers Squibb
Yervoy blocks a protein called CTLA-4, which normally helps to turn off the immune system, allowing it to attack cancer cells. - Pembrolizuma · Memorial Sloan Kettering Cancer Center
- Yervoy · Bristol-Myers Squibb
- Opdivo · Bristol-Myers Squibb
Opdivo works by blocking the PD-1 receptor on immune cells, allowing them to attack cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Microsatellite instability-high colorectal cancer patent landscape — cliff calendar, originator estates, attackable patents
- Microsatellite instability-high colorectal cancer treatment landscape brief
- Microsatellite instability-high colorectal cancer treatment updates RSS
Frequently asked questions about Microsatellite instability-high colorectal cancer
What drugs treat Microsatellite instability-high colorectal cancer?
Tracked treatments include Yervoy, Pembrolizuma, Opdivo.
What is the treatment for Microsatellite instability-high colorectal cancer?
Standard treatment for Microsatellite instability-high colorectal cancer includes Yervoy, Pembrolizuma, Opdivo. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Microsatellite instability-high colorectal cancer patent cliff · Microsatellite instability-high colorectal cancer CI report
- Treatment: Yervoy · Bristol-Myers Squibb
- Treatment: Pembrolizuma · Memorial Sloan Kettering Cancer Center
- Treatment: Yervoy · Bristol-Myers Squibb
- Treatment: Opdivo · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing